Clinical Trial

Continuous Remote Haemodynamic Monitoring With CardioMEMS™ Following Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension:

Study acronym: CARDIOMEMSCTPH
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is potentially curable by pulmonary endarterectomy (PEA), although a substantial proportion of patients develop residual pulmonary hypertension despite successful surgery. Currently, postoperative haemodynamic assessment relies on intermittent right heart catheterization, which does not provide information on the temporal evolution of pulmonary artery pressures during recovery. The CTEPH-CardioMEMS study is a prospective, single-centre observational study evaluating the feasibility and clinical utility of continuous haemodynamic monitoring using the CardioMEMS™ system implanted intraoperatively during PEA. The primary objective is to characterize the postoperative trajectory of mean pulmonary artery pressure (mPAP), determine the time to haemodynamic stabilization, and explore the relationship between continuous pressure monitoring and clinical, echocardiographic, invasive haemodynamic and functional recovery.
Trial Details
NCT Number NCT07758179
Lead Sponsor Hospital Universitario 12 de Octubre
Collaborators: Fundación para la Investigación Biomédica Hospital Universitario 12 de Octubre, Complutense, Universidad Complutense de Madrid
Conditions Chronic Thromboembolic Pulmonary Hypertension, Residual Pulmonary Hypertension
Enrollment 30 participants
Start Date 2026-10-01
Primary Completion 2028-10-01 (estimated)
Study Completion 2029-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11